Skip to main content

Neurology

FDA Approvals, Neurology
AXS-07 Gets Nod for Acute Migraine Treatment
Read More
Neurology
FDA Approves Lecanemab-irmb IV Maintenance Dosing for Early Alzheimer’s Treatment
Read More
Original Research, Practice Management, Neurology
A Retrospective Cost Analysis of Patients Who Switched from OnabotulinumtoxinA to IncobotulinumtoxinA in a Private Neurology Practice
Victoria K. Karschney; David R. Greeley, MD, FAAN
Read More

Results 1 - 3 of 3